Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes
published in: Journal of Cellular and Molecular Medicine
date of publication: 2020-09-17
main subject: murine model, empagliflozin
Cites articles
There is nothing here
Article - wd:Q99560199